Humanized L243 antibodies
Details for Australian Patent Application No. 2006218454 (hide)
International Classifications
Event Publications
27 September 2007 PCT application entered the National Phase
PCT publication WO2006/094192 Priority application(s): WO2006/094192
2 December 2010 Amendment Made
The nature of the amendment is: Amend co-inventor name from Chang, Chen-Hsing to Chang, ChienHsing 2006266529 GE Healthcare Bio-Sciences AB The nature of the amendment is: Amend co-inventor name from Brannholm, Maria to Holm, Maria
17 November 2011 Application Accepted
Published as AU-B-2006218454
15 March 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006218449-Phthalazine, azaand diazaphthalazine compounds and methods of use
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser